seed
Stage
1
Investors
About
Aurobac Therapeutics develops therapeutics targeting bacterial resistance mechanisms to treat antibiotic-resistant infections.
Explore Aurobac Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.